144 related articles for article (PubMed ID: 38823049)
1. Outcomes, complications, and dosing of intrathecal baclofen in the treatment of multiple sclerosis: a systematic review.
Cozzi FM; Zuckerman D; Sacknovitz A; Gozum N; Syal A; Danisi F; Sukul V
Neurosurg Focus; 2024 Jun; 56(6):E14. PubMed ID: 38823049
[TBL] [Abstract][Full Text] [Related]
2. Intrathecal Baclofen Therapy in Patients With Multiple Sclerosis: Improved Outcomes and Reduced Costs Through Identification of Catheter Malfunction.
Nelson MES; McGuire JR
Neuromodulation; 2019 Oct; 22(7):839-842. PubMed ID: 31157471
[TBL] [Abstract][Full Text] [Related]
3. Early outcomes after intrathecal baclofen therapy in ambulatory patients with multiple sclerosis.
Lee BS; Jones J; Lang M; Achey R; Dai L; Lobel DA; Nagel SJ; Machado AG; Bethoux F
J Neurosurg; 2018 Oct; 129(4):1056-1062. PubMed ID: 29192855
[TBL] [Abstract][Full Text] [Related]
4. Intrathecal baclofen for multiple sclerosis related spasticity: A twenty year experience.
Sammaraiee Y; Yardley M; Keenan L; Buchanan K; Stevenson V; Farrell R
Mult Scler Relat Disord; 2019 Jan; 27():95-100. PubMed ID: 30366276
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal baclofen efficacy for managing motor function and spasticity severity in patients with cerebral palsy: a systematic review and meta-analysis.
Masrour M; Zare A; Presedo A; Nabian MH
BMC Neurol; 2024 Apr; 24(1):143. PubMed ID: 38678195
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Dosing of Intrathecal Baclofen in the Treatment of Spasticity After Acquired Brain Injury.
Maneyapanda MB; McCormick ZL; Marciniak C; Reger C
PM R; 2017 Jun; 9(6):556-562. PubMed ID: 28082177
[TBL] [Abstract][Full Text] [Related]
7. Long-term intrathecal baclofen: outcomes after more than 10 years of treatment.
Mathur SN; Chu SK; McCormick Z; Chang Chien GC; Marciniak CM
PM R; 2014 Jun; 6(6):506-513.e1. PubMed ID: 24355547
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the cognitive benefits of intrathecal baclofen pump implantation in people with intractable multiple sclerosis related spasticity.
Farrell R; Summers M; Doogan C; Mulhert N; Keenan E; Buchanan K; Lee H; Padilla H; Stevenson VL
Mult Scler Relat Disord; 2021 May; 50():102831. PubMed ID: 33618123
[TBL] [Abstract][Full Text] [Related]
9. [Quality of life in cerebral palsy children treated with intrathecal baclofen pump implantation in parents' opinion].
Borowski A; Pruszczyński B; Miller F; Synder M
Chir Narzadow Ruchu Ortop Pol; 2010; 75(5):318-22. PubMed ID: 21853903
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the impact of intrathecal baclofen on the walking ability of people with Multiple Sclerosis related spasticity.
Sammaraiee Y; Stevenson VL; Keenan E; Buchanan K; Lee H; Padilla H; Farrell RA
Mult Scler Relat Disord; 2020 Nov; 46():102503. PubMed ID: 33032053
[TBL] [Abstract][Full Text] [Related]
11. Intraventricular baclofen as an alternative to intrathecal baclofen for intractable spasticity or dystonia: outcomes and technical considerations.
Turner M; Nguyen HS; Cohen-Gadol AA
J Neurosurg Pediatr; 2012 Oct; 10(4):315-9. PubMed ID: 22861196
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of severe spacticity in multiple sclerosis by continuous intrathecal baclofen].
Perić P; Antić B; Dincić E; Obradović D; Arsić S
Vojnosanit Pregl; 2006 Feb; 63(2):187-91. PubMed ID: 16502996
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of intrathecal baclofen in multiple sclerosis.
Natale M; D'Oria S; Nero VV; Squillante E; Gentile M; Rotondo M
Clin Neurol Neurosurg; 2016 Apr; 143():121-5. PubMed ID: 26922704
[TBL] [Abstract][Full Text] [Related]
14. Treatment of severe, disabling spasticity with continuous intrathecal baclofen therapy following acquired brain injury: the experience of a tertiary institution in Singapore.
Wang ZM; Law JH; King NK; Rajeswaran DK; Soh S; Rao JP; Ng WH; Chua KS
Singapore Med J; 2016 Jan; 57(1):8-12. PubMed ID: 26831310
[TBL] [Abstract][Full Text] [Related]
15. Intrathecal Baclofen in Spinal Spasticity: Frequency and Severity of Withdrawal Syndrome.
Stetkarova I; Brabec K; Vasko P; Mencl L
Pain Physician; 2015; 18(4):E633-41. PubMed ID: 26218954
[TBL] [Abstract][Full Text] [Related]
16. Intrathecal baclofen for spasticity-related pain in amyotrophic lateral sclerosis: efficacy and factors associated with pain relief.
McClelland S; Bethoux FA; Boulis NM; Sutliff MH; Stough DK; Schwetz KM; Gogol DM; Harrison M; Pioro EP
Muscle Nerve; 2008 Mar; 37(3):396-8. PubMed ID: 17894358
[TBL] [Abstract][Full Text] [Related]
17. Spasticity and intrathecal baclofen.
Furr-Stimming E; Boyle AM; Schiess MC
Semin Neurol; 2014 Nov; 34(5):591-6. PubMed ID: 25520030
[TBL] [Abstract][Full Text] [Related]
18. Effect of Intrathecal Baclofen on Pain and Quality of Life in Poststroke Spasticity.
Creamer M; Cloud G; Kossmehl P; Yochelson M; Francisco GE; Ward AB; Wissel J; Zampolini M; Abouihia A; Calabrese A; Saltuari L
Stroke; 2018 Sep; 49(9):2129-2137. PubMed ID: 30354975
[TBL] [Abstract][Full Text] [Related]
19. Intrathecal baclofen for treating spasticity in children with cerebral palsy.
Hasnat MJ; Rice JE
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD004552. PubMed ID: 26563961
[TBL] [Abstract][Full Text] [Related]
20. Clinical and neurophysiologic assessment of strength and spasticity during intrathecal baclofen titration in incomplete spinal cord injury: single-subject design.
Bowden M; Stokic DS
J Spinal Cord Med; 2009; 32(2):183-90. PubMed ID: 19569466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
